Increased Prevalence of Atopic Dermatitis in Children Aged 0-3 Years Highly Exposed to Parabens

Johichi Arafune1, Hiromasa Tsujiguchi1,2, Akinori Hara1,2

  • 1Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Insights

Exposure to parabens, common in consumer products, may increase the risk of atopic dermatitis in young children. This study suggests a link between higher paraben levels and increased allergy prevalence.

Area of Science:

  • Environmental Health
  • Dermatology
  • Pediatrics

Background:

  • Rising prevalence of allergic diseases globally.
  • Parabens (CAS number, 94-13-3) are widely used antimicrobial preservatives in consumer products.
  • Uncertainty exists regarding parabens' role in inducing or worsening allergies.

Purpose of the Study:

  • To investigate the association between paraben exposure and allergic disease prevalence in Japanese children.
  • To assess if parabens contribute to the development or exacerbation of allergies.

Main Methods:

  • Cross-sectional epidemiological study of 236 children aged 0-3 years in Shika town, Japan.
  • Exposure assessment via urinary paraben concentrations.
  • Statistical analysis adjusted for confounding factors like age, sex, Kaup's index, and passive smoking.

Main Results:

  • A significant positive correlation was found between high urinary paraben concentrations and the prevalence of atopic dermatitis (p < 0.001).
  • This association remained statistically significant after adjusting for potential confounders (p < 0.001).

Conclusions:

  • The study suggests a potential relationship between atopic dermatitis and exposure to parabens in children.
  • Further longitudinal research with larger sample sizes and detailed assessments (e.g., EASI scores) is recommended.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
31
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Allergic Reactions02:06

Allergic Reactions

Overview
29.2K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.6K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
424
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
24